What is LOPJLB’s current signal on FHTX?

LOPJLB’s latest quantitative signal on Foghorn Therapeutics Inc. (FHTX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is FHTX in?

Foghorn Therapeutics Inc. (FHTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Foghorn Therapeutics Inc. (FHTX) do?

Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing medicines. Their focus is on addressing genetically determined vulnerabilities within the chromatin regulatory system. The company employs its exclusive "Gene Traffic Control" platform to pinpoint, validate, and strategize drug development for specific targets within this complex syst…

Foghorn Therapeutics Inc. (FHTX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.85-5.13%Close

SELLCRISIS · day 32

Company news

globenewswire.com · 1d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX

gurufocus.com · 3d ago

FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law

businesswire.com · 3d ago

FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law

prnewswire.com · 6d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX

globenewswire.com · 8d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX

benzinga.com · 13d ago

Foghorn Therapeutics Pivots Pipeline after Ending Eli Lilly Deal

barrons.com · 14d ago

Foghorn to Slash 40% of Jobs as Lilly Cancer Partnership Falls Apart

globenewswire.com · 14d ago

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

zacks.com · 49d ago

Wall Street Analysts Think Foghorn Therapeutics (FHTX) Could Surge 67.01%: Read This Before Placing a Bet

zacks.com · 61d ago

Here's Why Foghorn Therapeutics Inc. (FHTX) is a Great Momentum Stock to Buy

zacks.com · 65d ago

Wall Street Analysts Believe Foghorn Therapeutics (FHTX) Could Rally 88.47%: Here's is How to Trade

zacks.com · 69d ago

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates

globenewswire.com · 70d ago

Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update

defenseworld.net · 77d ago

Reviewing Foghorn Therapeutics (NASDAQ:FHTX) and Sunshine Biopharma (NASDAQ:SBFM)

Market news & ticker search · RSS for FHTX

FAQ

What is LOPJLB’s current signal on FHTX?: LOPJLB’s latest quantitative signal on Foghorn Therapeutics Inc. (FHTX) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is FHTX in?: Foghorn Therapeutics Inc. (FHTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Foghorn Therapeutics Inc. (FHTX) do?: Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing medicines. Their focus is on addressing genetically determined vulnerabilities within the chromatin regulatory system. The company employs its exclusive "Gene Traffic Control" platform to pinpoint, validate, and strategize drug development for specific targets within this complex syst…

Foghorn Therapeutics Inc. (FHTX)

Key stats

Prediction markets

Company news

FAQ